SCHEMBL19081618

SCHEMBL19081618

c1ccc(-c2c3ccccc3c(-c3ccc(-c4cc5oc6ccccc6c5c5c4oc4cc6ccccc6cc45)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.37
ESR2 Q92731 4/20 0.37
CDC14B O60729 2/20 0.36
CDC14A Q9UNH5 2/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
KDM4E B2RXH2 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
GAA P10253 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP3A4 P08684 2/20 0.35
HPGD P15428 2/20 0.35
ALPI P09923 1/20 0.35
PKM P14618 1/20 0.35
CASP3 P42574 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081436 0.94 ESR1 (0.39) ESR1ESR2CDC14BCDC14ACA1
SCHEMBL17944829 0.91 CDC14B (0.41) ESR2CDC14BCDC14ACA1CA2
SCHEMBL19081652 0.90 ALOX5 (0.36) KDM4EL3MBTL1GAAHSD17B10MEN1
SCHEMBL19081524 0.88 ESR1 (0.37) ESR1ESR2CDC14BCDC14ACA1
SCHEMBL19081612 0.88 KDM4E (0.38) ESR1ESR2CDC14BCDC14ACA1
SCHEMBL19081615 0.87 ESR1 (0.36) ESR1ESR2CDC14BCDC14ACA1
SCHEMBL24614671 0.87 ESR1 (0.36) ESR1ESR2CDC14BCDC14ACA1
SCHEMBL24614747 0.86 ESR1 (0.39) ESR1ESR2CDC14BCDC14ACA1
SCHEMBL19080016 0.86 ESR1 (0.41) ESR1ESR2KDM4EMEN1MAPT
SCHEMBL19081705 0.85 AHR (0.36) ESR1ESR2CDC14BCDC14ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885CDC14B 3173/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885CDC14B 3173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.